PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PTC Therapeutics (NASDAQ: PTCT) has announced that its CEO, Matthew B. Klein, M.D., will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.
The event will be accessible via webcast on PTC Therapeutics' website under the Investors section's Events and Presentations page. Viewers can access the webcast at https://ir.ptcbio.com/events-presentations, and the recording will remain available for 30 days after the presentation. Attendees are advised to connect several minutes before the start time to ensure proper connection.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato che il suo CEO, Matthew B. Klein, M.D., terrà una presentazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. La presentazione è programmata per lunedì 13 gennaio 2025, alle 11:15 PST / 14:15 EST.
L'evento sarà accessibile in diretta tramite webcast sul sito web di PTC Therapeutics, nella sezione Eventi e Presentazioni per gli Investitori. Gli spettatori possono accedere al webcast su https://ir.ptcbio.com/events-presentations, e la registrazione rimarrà disponibile per 30 giorni dopo la presentazione. Si consiglia ai partecipanti di collegarsi alcuni minuti prima dell'orario d'inizio per garantire una connessione adeguata.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado que su CEO, Matthew B. Klein, M.D., presentará en la 43ª Conferencia Anual J.P. Morgan Healthcare. La presentación está programada para lunes 13 de enero de 2025, a las 11:15 a.m. PST / 2:15 p.m. EST.
El evento será accesible a través de un webcast en el sitio web de PTC Therapeutics, en la sección de Eventos y Presentaciones para Inversores. Los espectadores pueden acceder al webcast en https://ir.ptcbio.com/events-presentations, y la grabación permanecerá disponible durante 30 días después de la presentación. Se recomienda a los asistentes conectarse varios minutos antes de la hora de inicio para asegurar una conexión adecuada.
PTC Therapeutics (NASDAQ: PTCT)는 CEO인 Matthew B. Klein, M.D.가 제43회 연례 J.P. Morgan Healthcare 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 2025년 1월 13일 월요일 오전 11:15 PST / 오후 2:15 EST로 예정되어 있습니다.
이번 행사는 PTC Therapeutics 웹사이트의 투자자 섹션, 이벤트 및 프레젠테이션 페이지를 통해 웹캐스트로 접근할 수 있습니다. 시청자는 https://ir.ptcbio.com/events-presentations에서 웹캐스트에 접근할 수 있으며, 발표 후 30일 동안 녹화본이 제공됩니다. 참석자들은 올바른 연결을 보장하기 위해 시작 시간 몇 분 전에 연결할 것을 권장합니다.
PTC Therapeutics (NASDAQ: PTCT) a annoncé que son PDG, Matthew B. Klein, M.D., présentera lors de la 43ème Conférence Annuelle J.P. Morgan Healthcare. La présentation est prévue pour lundi 13 janvier 2025, à 11h15 PST / 14h15 EST.
L'événement sera accessible en direct via un webcast sur le site de PTC Therapeutics, dans la section Événements et Présentations pour les Investisseurs. Les spectateurs peuvent accéder au webcast sur https://ir.ptcbio.com/events-presentations, et l'enregistrement restera disponible pendant 30 jours après la présentation. Il est conseillé aux participants de se connecter quelques minutes avant l'heure de début pour garantir une connexion adéquate.
PTC Therapeutics (NASDAQ: PTCT) hat bekannt gegeben, dass sein CEO, Matthew B. Klein, M.D., eine Präsentation auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz halten wird. Die Präsentation ist für Montag, den 13. Januar 2025, um 11:15 Uhr PST / 14:15 Uhr EST angesetzt.
Die Veranstaltung wird über einen Webcast auf der Website von PTC Therapeutics im Bereich Veranstaltungen und Präsentationen für Investoren zugänglich sein. Zuschauer können über https://ir.ptcbio.com/events-presentations auf den Webcast zugreifen, und die Aufzeichnung bleibt 30 Tage nach der Präsentation verfügbar. Den Teilnehmern wird empfohlen, sich einige Minuten vor Beginn der Veranstaltung zu verbinden, um eine ordnungsgemäße Verbindung zu gewährleisten.
- None.
- None.
The presentation will be webcast live on the Events and Presentations page under the Investors section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and X.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302338079.html
SOURCE PTC Therapeutics, Inc.
FAQ
When is PTC Therapeutics (PTCT) presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will PTCT's J.P. Morgan Healthcare Conference presentation be available for viewing?
Where can investors watch PTC Therapeutics' J.P. Morgan Healthcare Conference presentation?
Who will be presenting for PTCT at the 2025 J.P. Morgan Healthcare Conference?
